LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

McKesson Corp

Отворен

СекторЗдравеопазване

865.19 0.62

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

857.1

Максимум

869.8

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

25.318

57.05

Дивидентна доходност

0.35

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+15.24% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.35%

2.52%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.04.2026 г.

Следваща дата на екс-дивидент

1.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

3B

108B

Предишно отваряне

864.57

Предишно затваряне

865.19

Настроения в новините

By Acuity

17%

83%

26 / 349 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.03.2026 г., 17:33 ч. UTC

Значими събития в новините

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27.03.2026 г., 17:00 ч. UTC

Значими събития в новините

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27.03.2026 г., 16:03 ч. UTC

Значими събития в новините

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29.03.2026 г., 23:47 ч. UTC

Пазарно говорене
Значими събития в новините

Gold Falls Amid Rising Inflation Fears -- Market Talk

29.03.2026 г., 23:46 ч. UTC

Пазарно говорене
Значими събития в новините

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29.03.2026 г., 23:35 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29.03.2026 г., 23:23 ч. UTC

Пазарно говорене

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29.03.2026 г., 22:34 ч. UTC

Пазарно говорене

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29.03.2026 г., 22:09 ч. UTC

Пазарно говорене

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29.03.2026 г., 21:06 ч. UTC

Пазарно говорене
Значими събития в новините

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29.03.2026 г., 21:03 ч. UTC

Пазарно говорене

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29.03.2026 г., 21:01 ч. UTC

Пазарно говорене
Значими събития в новините

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29.03.2026 г., 09:30 ч. UTC

Придобивния, сливания и поглъщания

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28.03.2026 г., 08:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

27.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

27.03.2026 г., 19:16 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27.03.2026 г., 19:07 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27.03.2026 г., 19:04 ч. UTC

Пазарно говорене

Gold Rises But Can't Finish the Week Positive -- Market Talk

27.03.2026 г., 19:03 ч. UTC

Пазарно говорене
Значими събития в новините

Global Forex and Fixed Income Roundup: Market Talk

27.03.2026 г., 19:02 ч. UTC

Пазарно говорене
Значими събития в новините

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27.03.2026 г., 18:12 ч. UTC

Пазарно говорене

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27.03.2026 г., 17:36 ч. UTC

Значими събития в новините

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27.03.2026 г., 17:34 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27.03.2026 г., 17:29 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27.03.2026 г., 16:38 ч. UTC

Пазарно говорене

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27.03.2026 г., 16:32 ч. UTC

Пазарно говорене
Значими събития в новините

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27.03.2026 г., 16:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

27.03.2026 г., 15:43 ч. UTC

Пазарно говорене
Значими събития в новините

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27.03.2026 г., 15:25 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

27.03.2026 г., 15:25 ч. UTC

Пазарно говорене

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

15.24% нагоре

12-месечна прогноза

Среден 991.22 USD  15.24%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

26 / 349 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat